---
title: "Biotron Limited Appoints Michael Medway as Non-Executive Director"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/248700720.md"
description: "Biotron Limited has appointed Michael Medway as a Non-Executive Director, effective immediately. With over 30 years of experience in the professional accounting industry, Medway's expertise is expected to enhance Biotron’s strategic direction and governance. The company focuses on developing antiviral therapies and aims to address unmet medical needs in the biotechnology sector. Current market cap stands at A$2.65M."
datetime: "2025-07-16T01:42:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248700720.md)
  - [en](https://longbridge.com/en/news/248700720.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248700720.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/248700720.md) | [繁體中文](https://longbridge.com/zh-HK/news/248700720.md)


# Biotron Limited Appoints Michael Medway as Non-Executive Director

### Elevate Your Investing Strategy:

-   Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
-   Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.

Biotron ( (AU:BIT) ) just unveiled an announcement.

Biotron Limited has appointed Mr. Michael Medway as a Non-Executive Director, effective immediately. Mr. Medway brings over 30 years of experience in the professional accounting industry, having served as a Chartered Accountant and director for various enterprises. His expertise is expected to enhance Biotron’s strategic direction and strengthen its governance, potentially impacting its operational efficiency and industry positioning positively.

**More about Biotron**

Biotron Limited operates in the biotechnology industry, focusing on the development of antiviral therapies. The company is engaged in research and development to create innovative treatments for viral infections, aiming to address unmet medical needs in the market.

**Technical Sentiment Signal:** Sell

**Current Market Cap:** A$2.65M

For an in-depth examination of BIT stock, go to TipRanks’ Overview page.

## Trending Articles:

-   Can Amazon Gain 35%? Top Analyst Cites Improving Macro Backdrop and AWS Strength
-   Tesla Price Target Trimmed by Top Analyst Despite Improving U.S. Auto Outlook
-   3 “Strong Buy” Technology Stocks to Buy Now, 7/11/25, According to Top Analysts

Disclaimer & DisclosureReport an Issue

### 相关股票

- [Biotron Limited (BIT.AU)](https://longbridge.com/zh-CN/quote/BIT.AU.md)

## 相关资讯与研究

- [Here's How Much $100 Invested In abrdn Physical Silver Shares ETF 10 Years Ago Would Be Worth Today](https://longbridge.com/zh-CN/news/281394387.md)
- [Destiny Tech100 Stock Rises After SpaceX IPO Rumors](https://longbridge.com/zh-CN/news/281415250.md)
- [BREAKINGVIEWS-SpaceX IPO will gauge market moxie more than depth](https://longbridge.com/zh-CN/news/281406751.md)
- [Palantir vs. Oracle: 1 AI Stock Looks Cheap](https://longbridge.com/zh-CN/news/281400403.md)
- [BUZZ-Rosenblatt says finding partner for Snap's smart glasses unit tough](https://longbridge.com/zh-CN/news/281357569.md)